三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
KEYNOTE-042研究:疗效终点(5年随访)
KEYNOTE-042研究:疗效终点(5年随访)
其它
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:94KB
图片尺寸:1819*760
同报告图片
/
4
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
所属报告:
康方生物-港股公司研究报告-决胜肺癌依沃西单抗带来新曙光-240626(22页).pdf
打包全文图表
相关数据
KEYNOTE-942研究中RFS与DMFS数据
fCDlj4LmlbAgfCBtUk5BLTQxNTcgKFY5NDApICsgcGVtYnJvbGl6dW1hYiB8IFBlbWJyb2xpenVtYWIgfAp8IC0tLSB8IC0tLSB8IC0tLSB8CnwgTWVkaWFuICg5NSUgQ0kpLCBtb250aHMgfCBORSB8IDQyLjUgKDE2LjU5LU5FKSB8CnwgRXZlbnRzLCBuL04gfCAyMy40ICgyNS8xMDcpIHwgNDQuMCAoMjIvNTApIHwKfCBIYXphcmQgcmF0aW8gKDk1JSBDSSkqIHwgMC41MTAgKDAuMjg4LTAuOTA2KSB8IC0gfAp8IFAgfCAwLjAxOSogfCAtIHwKCui1hOaWmeadpea6kO+8mk1vZGVybmHlrpjnvZHvvIzpuqbpq5jor4HliLjnoJTnqbblj5HlsZXpg6g=
收藏
行业数据
2025-05-15
原图定位
查看详情
KEYNOTE-042研究(PD-L1TPS1-49%)
fCBUaW1lIHNpbmNlIHJhbmRvbWlzYXRpb24gKG1vbnRocykgfCBQZW1icm9saXp1bWFiIHwgQ2hlbW90aGVyYXB5IHwKfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS18CnwgMCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDEuMDAgICAgICAgICAgfCAxLjAwICAgICAgICAgfAp8IDYgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCAwLjc1ICAgICAgICAgIHwgMC43NSAgICAgICAgIHwKfCAxMiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgMC42MCAgICAgICAgICB8IDAuNjAgICAgICAgICB8CnwgMTggICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDAuNTAgICAgICAgICAgfCAwLjUwICAgICAgICAgfAp8IDI0ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCAwLjQ1ICAgICAgICAgIHwgMC40NSAgICAgICAgIHwKfCAzMCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgMC40MCAgICAgICAgICB8IDAuNDAgICAgICAgICB8CnwgMzYgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDAuMzUgICAgICAgICAgfCAwLjM1ICAgICAgICAgfAp8IDQyICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCAwLjMwICAgICAgICAgIHwgMC4zMCAgICAgICAgIHwKCui1hOaWmeadpea6kDogTGFuY2V0IDIwMTk7IDM5MzogMTgxOeKAkzMwLCDljY7npo/or4HliLjnoJTnqbbmiYAgKOe6tei9tDogT1Mp
收藏
其它
2024-07-10
原图定位
查看详情
KEYNOTE-189研究(PD-L1TPS1-49%)
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
收藏
其它
2024-07-10
原图定位
查看详情
KEYNOTE-042研究:PD-L1TPS≥1%患者的PFS(3年跟踪)
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
收藏
其它
2024-06-27
原图定位
查看详情
KEYNOTE-024研究:生存期获益(5年随访)
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
收藏
其它
2024-06-27
原图定位
查看详情
KEYNOTE-024于2016ESMO公布的初步临床结果
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
收藏
行业数据
2023-07-20
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
5 年的跟踪证实了帕博利珠单抗单药治疗在 TPS ≥ 1%患者中的长期获益:1)与化疗相比,试验组取得了 16.4 vs 12.1 月(HR = 0.79)的显著 OS 优势;2)与 KEYNOTE-024 研究相似,KEYNOTE-042 研究中的 5 年 OS 率同样较化疗组接近翻倍(16.6% vs 8.5%);3)在中国患者人群及 KEYNOTE-042 中国扩展研究中,试验组较化疗组取得了 20.2 vs 13.5月(HR = 0.66)的显著 OS 优势和 19.0% vs 9.5%的 5 年 OS 率领先。然而,亚组分析显 示 KEYN OTE-042 研究中帕博利珠单抗组的患者获益主 要来自 TPS ≥ 50%的人群,TPS 1%~49%的患者 OS 的 HR 值在 95%置信区间的上限超过 1.0;TPS ≥ 1%患者的 PFS 为5.6 vs 6.8 月(HR = 1.03),两组无显著性差异。
其它
原图定位
当前图表所属:
康方生物-港股公司研究报告-决胜肺癌依沃西单抗带来新曙光-240626(22页).pdf
表现金流量
KEYNOTE-189研究:OS
KEYNOTE-189研究:PFS
KEYNOTE-042研究:疗效终点(5年随访)
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》